H.R.7567 - Helping Experts Accelerate Rare Treatments Act of 2020116th Congress (2019-2020)
|Sponsor:||Rep. Tonko, Paul [D-NY-20] (Introduced 07/09/2020)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 07/09/2020 Referred to the House Committee on Energy and Commerce. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.7567 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (07/09/2020)
Helping Experts Accelerate Rare Treatments Act of 2020
This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process.
The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as orphan drugs if the rarity of the disease makes it difficult for the drug to be profitable).